Holdings of Virtus Biotech Etf
ETFis Series Trust I · Original filing · Compare with another fund · Report an error
- Net assets
- 59.3M $ including 59M $ in equities, 99.5 %
- Positions
- 60 in 6 countries
- Top ten
- 25.5 % of net assets
- Filed on
- Apr 30, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ImmunityBio Inc | 401,005 | 2.8M $ | 4.80 % |
| 2 | Apellis Pharmaceuticals Inc | 37,509 | 1.5M $ | 2.59 % |
| 3 | KalVista Pharmaceuticals Inc | 55,964 | 1.5M $ | 2.52 % |
| 4 | Moderna Inc | 32,122 | 1.5M $ | 2.49 % |
| 5 | Iovance Biotherapeutics Inc | 430,167 | 1.4M $ | 2.44 % |
| 6 | Mirum Pharmaceuticals Inc | 14,558 | 1.4M $ | 2.39 % |
| 7 | Axsome Therapeutics Inc | 6,386 | 1.3M $ | 2.24 % |
| 8 | Kiniksa Pharmaceuticals International Plc | 22,754 | 1.2M $ | 2.06 % |
| 9 | Roivant Sciences Ltd | 42,821 | 1.2M $ | 2.06 % |
| 10 | ZAI LAB LTD | 53,256 | 1.2M $ | 1.94 % |
| 11 | Ligand Pharmaceuticals Inc | 4,992 | 1.1M $ | 1.93 % |
| 12 | BioCryst Pharmaceuticals Inc | 125,015 | 1.1M $ | 1.93 % |
| 13 | Travere Therapeutics Inc | 27,170 | 1.1M $ | 1.93 % |
| 14 | Novavax Inc | 144,044 | 1.1M $ | 1.93 % |
| 15 | United Therapeutics Corp | 1,914 | 1.1M $ | 1.84 % |
| 16 | Geron Corp | 695,861 | 1.1M $ | 1.81 % |
| 17 | BioNTech SE | 9,981 | 1M $ | 1.74 % |
| 18 | Amgen Inc | 2,977 | 1M $ | 1.74 % |
| 19 | Exelixis Inc | 23,148 | 1M $ | 1.74 % |
| 20 | Biogen Inc | 5,434 | 1M $ | 1.73 % |
| 21 | Gilead Sciences Inc | 7,859 | 1M $ | 1.73 % |
| 22 | TG Therapeutics Inc | 30,187 | 1M $ | 1.72 % |
| 23 | Krystal Biotech Inc | 3,866 | 1M $ | 1.71 % |
| 24 | LEGEND BIOTECH CORP | 42,398 | 997.2K $ | 1.68 % |
| 25 | Syndax Pharmaceuticals Inc | 46,457 | 995.6K $ | 1.68 % |
| 26 | Arrowhead Pharmaceuticals Inc | 13,501 | 992.1K $ | 1.67 % |
| 27 | Ascendis Pharma A/S | 4,293 | 984.7K $ | 1.66 % |
| 28 | Agios Pharmaceuticals Inc | 34,703 | 971.7K $ | 1.64 % |
| 29 | Halozyme Therapeutics Inc | 15,211 | 968.3K $ | 1.63 % |
| 30 | Ardelyx Inc | 152,393 | 964.6K $ | 1.63 % |
| 31 | BioMarin Pharmaceutical Inc | 17,750 | 956.9K $ | 1.61 % |
| 32 | Incyte Corp | 9,918 | 944.9K $ | 1.59 % |
| 33 | Aurinia Pharmaceuticals Inc | 59,707 | 918.6K $ | 1.55 % |
| 34 | Sarepta Therapeutics Inc | 43,955 | 917.8K $ | 1.55 % |
| 35 | Regeneron Pharmaceuticals, Inc. | 1,276 | 902.2K $ | 1.52 % |
| 36 | Bridgebio Pharma Inc | 12,592 | 895.4K $ | 1.51 % |
| 37 | Vertex Pharmaceuticals Inc | 2,093 | 894.5K $ | 1.51 % |
| 38 | BEONE MEDICINES LTD | 2,965 | 875.5K $ | 1.48 % |
| 39 | Ionis Pharmaceuticals Inc | 11,708 | 875.3K $ | 1.48 % |
| 40 | CRISPR Therapeutics AG | 16,695 | 873.8K $ | 1.47 % |
| 41 | Theravance Biopharma Inc | 52,082 | 871.9K $ | 1.47 % |
| 42 | Madrigal Pharmaceuticals Inc | 1,655 | 856.3K $ | 1.44 % |
| 43 | Kura Oncology Inc | 92,599 | 817.6K $ | 1.38 % |
| 44 | Neurocrine Biosciences Inc | 6,192 | 815.3K $ | 1.38 % |
| 45 | PTC Therapeutics Inc | 12,510 | 813.9K $ | 1.37 % |
| 46 | ACADIA Pharmaceuticals Inc | 34,855 | 782.5K $ | 1.32 % |
| 47 | Arcutis Biotherapeutics Inc | 32,610 | 757.2K $ | 1.28 % |
| 48 | Tarsus Pharmaceuticals Inc | 11,632 | 739.9K $ | 1.25 % |
| 49 | Alnylam Pharmaceuticals Inc | 2,379 | 736.3K $ | 1.24 % |
| 50 | Harmony Biosciences Holdings Inc | 23,360 | 730.2K $ | 1.23 % |
| 51 | Phathom Pharmaceuticals Inc | 64,997 | 728K $ | 1.23 % |
| 52 | Crinetics Pharmaceuticals Inc | 18,743 | 726.9K $ | 1.23 % |
| 53 | Immunocore Holdings PLC | 25,714 | 717.7K $ | 1.21 % |
| 54 | Rhythm Pharmaceuticals Inc | 8,333 | 678K $ | 1.14 % |
| 55 | Insmed Inc | 4,801 | 654.5K $ | 1.10 % |
| 56 | Ultragenyx Pharmaceutical Inc | 26,120 | 644.9K $ | 1.09 % |
| 57 | Nuvation Bio Inc | 112,261 | 499.6K $ | 0.84 % |
| 58 | Esperion Therapeutics Inc | 245,810 | 491.6K $ | 0.83 % |
| 59 | ADMA Biologics Inc | 47,844 | 490.4K $ | 0.83 % |
| 60 | LENZ Therapeutics Inc | 52,170 | 468.5K $ | 0.79 % |
Sector breakdown
- Health care 18.1 %
- Unattributed 81.9 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 89.5 %
- Cayman Islands 3.6 %
- Bermuda 2.1 %
- Germany 1.7 %
- Canada 1.6 %
- Switzerland 1.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 54 | 52.8M $ | 89.50 % |
| 2 | Cayman Islands | 2 | 2.1M $ | 3.64 % |
| 3 | Bermuda | 1 | 1.2M $ | 2.07 % |
| 4 | Germany | 1 | 1M $ | 1.75 % |
| 5 | Canada | 1 | 918.6K $ | 1.56 % |
| 6 | Switzerland | 1 | 873.8K $ | 1.48 % |
Cite this page
Titelia. "Holdings of Virtus Biotech Etf". https://titelia.com/en/funds/S000047354